# Zhejiang Better Pharmaceuticals Co., Ltd. – FDA Inspection, Jan 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-better-pharmaceuticals-co-ltd/7f3f48bd-c3a3-4dcb-8a6c-b354f1364c91
Source feed: FDA_Inspections

> FDA inspection 1005236 of Zhejiang Better Pharmaceuticals Co., Ltd., January 20, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1005236
- Company Name: Zhejiang Better Pharmaceuticals Co., Ltd.
- Inspection Date: 2017-01-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1252973 - 2024-09-26](https://www.keypedia.com/records/fda_inspections/zhejiang-better-pharmaceuticals-co-ltd/fcb73a00-e926-4ccd-8bc6-4e6040b5a9e6)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [FDA Associated Person](https://www.keypedia.com/people/yasamin-ameri/73021772-c960-4c65-aa30-cb490866ee58)

Company: https://www.keypedia.com/companies/zhejiang-better-pharmaceuticals-co-ltd/487aea91-5bd2-4eaf-ac4e-899ede833b28

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c